Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hermanski-Pudlak Syndrome | 3 | 2026 | 16 | 1.370 |
Why?
|
| Aminopyridines | 4 | 2025 | 26 | 1.200 |
Why?
|
| Oxazines | 4 | 2025 | 32 | 1.170 |
Why?
|
| Neutrophil Activation | 2 | 2025 | 9 | 1.140 |
Why?
|
| Pyridines | 4 | 2025 | 134 | 1.100 |
Why?
|
| Morpholines | 4 | 2025 | 73 | 1.030 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 1 | 2025 | 4 | 0.920 |
Why?
|
| Uteroglobin | 1 | 2025 | 9 | 0.910 |
Why?
|
| Shock, Septic | 2 | 2024 | 19 | 0.810 |
Why?
|
| Neutrophils | 4 | 2025 | 141 | 0.800 |
Why?
|
| Lipopolysaccharides | 2 | 2024 | 235 | 0.720 |
Why?
|
| Cytokines | 3 | 2025 | 661 | 0.660 |
Why?
|
| Kartagener Syndrome | 3 | 2025 | 3 | 0.650 |
Why?
|
| Macrophages, Peritoneal | 1 | 2018 | 23 | 0.590 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2018 | 24 | 0.580 |
Why?
|
| Helminth Proteins | 1 | 2018 | 23 | 0.580 |
Why?
|
| Klebsiella Infections | 2 | 2025 | 11 | 0.460 |
Why?
|
| Pulmonary Fibrosis | 2 | 2026 | 38 | 0.450 |
Why?
|
| Cell Movement | 1 | 2018 | 640 | 0.450 |
Why?
|
| Pyrimidines | 4 | 2025 | 130 | 0.340 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2020 | 112 | 0.300 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 1554 | 0.290 |
Why?
|
| Klebsiella pneumoniae | 2 | 2025 | 26 | 0.280 |
Why?
|
| Sepsis | 2 | 2025 | 90 | 0.270 |
Why?
|
| Autopsy | 2 | 2023 | 46 | 0.240 |
Why?
|
| Humans | 19 | 2026 | 42113 | 0.240 |
Why?
|
| Ciliary Motility Disorders | 1 | 2025 | 1 | 0.240 |
Why?
|
| Prognosis | 2 | 2026 | 847 | 0.240 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2025 | 5 | 0.230 |
Why?
|
| Naphthalenes | 1 | 2025 | 38 | 0.230 |
Why?
|
| Coordination Complexes | 1 | 2025 | 28 | 0.230 |
Why?
|
| Choline | 1 | 2026 | 61 | 0.230 |
Why?
|
| Multicenter Studies as Topic | 1 | 2025 | 61 | 0.230 |
Why?
|
| Male | 10 | 2026 | 22745 | 0.220 |
Why?
|
| Middle Aged | 5 | 2026 | 11790 | 0.220 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 357 | 0.200 |
Why?
|
| Female | 9 | 2026 | 23980 | 0.200 |
Why?
|
| Treatment Outcome | 2 | 2025 | 1582 | 0.200 |
Why?
|
| Organ Specificity | 1 | 2022 | 141 | 0.190 |
Why?
|
| Aged | 2 | 2025 | 7958 | 0.190 |
Why?
|
| Severity of Illness Index | 1 | 2025 | 704 | 0.190 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 7 | 0.180 |
Why?
|
| Myocarditis | 1 | 2021 | 24 | 0.180 |
Why?
|
| Retrospective Studies | 2 | 2025 | 2466 | 0.180 |
Why?
|
| Th1 Cells | 1 | 2021 | 97 | 0.180 |
Why?
|
| Interleukin-10 | 1 | 2021 | 86 | 0.170 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 26 | 0.170 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2020 | 22 | 0.170 |
Why?
|
| Epitopes | 1 | 2021 | 155 | 0.170 |
Why?
|
| Interferon-gamma | 1 | 2021 | 268 | 0.160 |
Why?
|
| RNA, Viral | 4 | 2023 | 317 | 0.160 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 72 | 0.160 |
Why?
|
| Adult | 6 | 2026 | 13437 | 0.160 |
Why?
|
| Mutation | 2 | 2023 | 1169 | 0.150 |
Why?
|
| Vitamin D | 1 | 2021 | 196 | 0.150 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 378 | 0.150 |
Why?
|
| Injections, Intravenous | 1 | 2018 | 65 | 0.150 |
Why?
|
| Cytosol | 1 | 2018 | 98 | 0.140 |
Why?
|
| Spleen | 1 | 2018 | 199 | 0.140 |
Why?
|
| Fatty Acids | 1 | 2018 | 134 | 0.140 |
Why?
|
| Young Adult | 2 | 2025 | 4928 | 0.130 |
Why?
|
| Membrane Glycoproteins | 1 | 2018 | 221 | 0.130 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 522 | 0.130 |
Why?
|
| Adolescent | 2 | 2025 | 5949 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2025 | 979 | 0.130 |
Why?
|
| Respiratory Function Tests | 2 | 2025 | 61 | 0.110 |
Why?
|
| Cells, Cultured | 1 | 2018 | 1617 | 0.110 |
Why?
|
| Brain | 1 | 2022 | 1449 | 0.110 |
Why?
|
| Cilia | 2 | 2024 | 29 | 0.100 |
Why?
|
| Macaca mulatta | 2 | 2025 | 139 | 0.100 |
Why?
|
| Animals | 4 | 2025 | 16694 | 0.090 |
Why?
|
| Mice | 1 | 2018 | 6490 | 0.070 |
Why?
|
| Peroxidase | 1 | 2025 | 57 | 0.060 |
Why?
|
| Spirometry | 1 | 2025 | 40 | 0.060 |
Why?
|
| Platinum | 1 | 2025 | 23 | 0.060 |
Why?
|
| Palladium | 1 | 2025 | 30 | 0.060 |
Why?
|
| Forced Expiratory Volume | 1 | 2025 | 75 | 0.060 |
Why?
|
| Pregnancy | 2 | 2020 | 1733 | 0.060 |
Why?
|
| Blood Coagulation Disorders | 1 | 2024 | 8 | 0.060 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2025 | 147 | 0.060 |
Why?
|
| Multiple Organ Failure | 1 | 2024 | 8 | 0.060 |
Why?
|
| Endotoxins | 1 | 2024 | 18 | 0.060 |
Why?
|
| Crystallography, X-Ray | 1 | 2025 | 285 | 0.060 |
Why?
|
| Cell Degranulation | 1 | 2024 | 10 | 0.050 |
Why?
|
| Bacteremia | 1 | 2024 | 37 | 0.050 |
Why?
|
| Critical Care | 1 | 2024 | 48 | 0.050 |
Why?
|
| Receptors, IgG | 1 | 2024 | 53 | 0.050 |
Why?
|
| Microscopy, Video | 1 | 2024 | 12 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2024 | 74 | 0.050 |
Why?
|
| Phagocytosis | 1 | 2024 | 83 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2025 | 491 | 0.050 |
Why?
|
| Imidazoles | 1 | 2024 | 138 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2024 | 237 | 0.050 |
Why?
|
| Axoneme | 1 | 2023 | 1 | 0.050 |
Why?
|
| HLA-DR Antigens | 1 | 2023 | 23 | 0.050 |
Why?
|
| Respiratory System | 1 | 2022 | 31 | 0.050 |
Why?
|
| Complement C3a | 1 | 2021 | 1 | 0.050 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2021 | 2 | 0.050 |
Why?
|
| Complement C3b | 1 | 2021 | 3 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 1 | 2023 | 114 | 0.050 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2021 | 17 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2022 | 305 | 0.050 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2021 | 54 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2025 | 875 | 0.040 |
Why?
|
| Homeostasis | 1 | 2023 | 191 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 518 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2021 | 82 | 0.040 |
Why?
|
| Oxygen | 1 | 2022 | 217 | 0.040 |
Why?
|
| Receptors, Calcitriol | 1 | 2021 | 69 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2021 | 97 | 0.040 |
Why?
|
| Algorithms | 1 | 2024 | 508 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 244 | 0.040 |
Why?
|
| Fetal Blood | 1 | 2020 | 48 | 0.040 |
Why?
|
| Virus Replication | 1 | 2022 | 318 | 0.040 |
Why?
|
| Proteins | 1 | 2023 | 383 | 0.040 |
Why?
|
| Placenta | 1 | 2020 | 113 | 0.040 |
Why?
|
| Postpartum Period | 1 | 2020 | 91 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2025 | 1420 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 599 | 0.040 |
Why?
|
| Hospitalization | 1 | 2022 | 477 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 2598 | 0.030 |
Why?
|
| Time Factors | 1 | 2022 | 1845 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2020 | 960 | 0.030 |
Why?
|
| Inflammation | 1 | 2023 | 729 | 0.030 |
Why?
|
| Apoptosis | 1 | 2025 | 1541 | 0.030 |
Why?
|
| Cell Line | 1 | 2021 | 1416 | 0.030 |
Why?
|
| Child | 1 | 2025 | 3381 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2021 | 2111 | 0.020 |
Why?
|